Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
Animals
Apoptosis
Autoantigens
/ genetics
Biomarkers, Tumor
/ genetics
Cell Movement
Cell Proliferation
Checkpoint Kinase 1
/ genetics
Female
Gene Expression Regulation, Neoplastic
Glioblastoma
/ genetics
Humans
Intracellular Signaling Peptides and Proteins
/ genetics
Membrane Proteins
/ genetics
Mice
Mice, Inbred BALB C
Mice, Inbred NOD
Mice, Nude
Mice, SCID
Phosphorylation
Prognosis
STAT3 Transcription Factor
/ genetics
Survival Rate
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Journal
Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
16
09
2019
revised:
14
01
2020
accepted:
17
02
2020
pubmed:
23
2
2020
medline:
6
3
2021
entrez:
22
2
2020
Statut:
ppublish
Résumé
High-constitutive activity of the DNA damage response protein checkpoint kinase 1 (CHK1) has been shown in glioblastoma (GBM) cell lines and in tissue sections. However, whether constitutive activation and overexpression of CHK1 in GBM plays a functional role in tumorigenesis or has prognostic significance is not known. We interrogated multiple glioma patient cohorts for expression levels of CHK1 and the oncogene cancerous inhibitor of protein phosphatase 2A (CIP2A), a known target of high-CHK1 activity, and examined the relationship between these two proteins in GBM. Expression levels of CHK1 and CIP2A were independent predictors for reduced overall survival across multiple glioma patient cohorts. Using siRNA and pharmacologic inhibitors we evaluated the impact of their depletion using both
Identifiants
pubmed: 32079743
pii: 1541-7786.MCR-19-0934
doi: 10.1158/1541-7786.MCR-19-0934
doi:
Substances chimiques
Autoantigens
0
Biomarkers, Tumor
0
CIP2A protein, human
0
Intracellular Signaling Peptides and Proteins
0
Membrane Proteins
0
STAT3 Transcription Factor
0
STAT3 protein, human
0
CHEK1 protein, human
EC 2.7.11.1
Checkpoint Kinase 1
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
709-722Informations de copyright
©2020 American Association for Cancer Research.